Glaukos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.

About GKOS

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. 

CEO
Thomas William Burns
CEOThomas William Burns
Employees
995
Employees995
Headquarters
Aliso Viejo, California
HeadquartersAliso Viejo, California
Founded
1998
Founded1998
Employees
995
Employees995

GKOS Key Statistics

Market cap
5.58B
Market cap5.58B
Price-Earnings ratio
-42.85
Price-Earnings ratio-42.85
Dividend yield
Dividend yield
Average volume
764.09K
Average volume764.09K
High today
$100.32
High today$100.32
Low today
$97.70
Low today$97.70
Open price
$99.82
Open price$99.82
Volume
598.59K
Volume598.59K
52 Week high
$163.71
52 Week high$163.71
52 Week low
$77.10
52 Week low$77.10

GKOS News

Simply Wall St 5d
Breakeven On The Horizon For Glaukos Corporation

With the business potentially at an important milestone, we thought we'd take a closer look at Glaukos Corporation's ( ) future prospects. Glaukos Corporation,...

Breakeven On The Horizon For Glaukos Corporation

Analyst ratings

75%

of 16 ratings
Buy
75%
Hold
18.8%
Sell
6.3%

People also own

Based on the portfolios of people who own GKOS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.